Effect of concomitant gastroesophageal reflux disease on the course of arterial hypertension and chronic coronary artery disease in elderly patients

Authors

  • L. A. Stadniuk Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine,
  • D. Yu. Moreva Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine,

DOI:

https://doi.org/10.22141/2306-2436.8.1.2019.172615

Keywords:

elderly patients, arterial hypertension, coronary heart disease, gastroesophageal reflux disease

Abstract

Background. The purpose was to study the characteristics of the course of arterial hypertension (AH) and coronary artery disease (CAD) in the presence of concomitant gastroesophageal reflux disease (GERD) in elderly patients. Materials and methods. A total of 107 patients at the age of 44 to 78 years with hypertension and chronic coronary artery disease were examined, of which 65 patients had concomitant GERD. A comprehensive survey was conducted on the background of the constant conventional treatment of hypertension and coronary artery disease, as well as after joining a parallel 12-week treatment of GERD. Results. When combined with hypertension and coronary artery disease with GERD 41 (63.1%) patients with GERD had a background hernia of the esophageal opening of the diaphragm (HHL). Among GERD patients, 32.3% had obesity II and III degrees. In the presence of HHL, patients more often had burn at night and belching sour. Patients with AH and CAD with GERD were more likely to have atrial fibrillation (AF), supraventricular and ventricular extrasistolia, and episodes of S-T segment depression with daily ECG monitoring, as well as a greater increase in blood pressure. After adhering to a course of treatment for GERD, along with a decrease in clinical and morphological manifestations of GERD, there was a decrease in the severity of hypertension, the frequency of detection of polytopic extrasystoles and episodes of depression of the S-T segment during ECG monitoring. The improvement in the course of CAD and hypertension with adequate treatment of concomitant GERD can be explained by the prevention of vagal-vagal reflexes. Conclusions. To improve the effectiveness of treatment of hypertension and CAD it is important to timely identify the concomitant GERH and adequately treat it.

References

Комаров Ф. И. Руководство по гастроэнтерологии/ Ф. И. Комаров, С. И. Рапопорт, редакторы // М.: МИА. – 2010. - 859 с.

Тамулевичюте Д. Ю. Болезни пищевода и кардии. 2-е изд., перераб. и доп. / Д. Ю. Тамулевичюте // М.: Медицина. - 1986.- 223 с.

Уварова Н. А. Особенности клинико-эндоскопических проявлений грыжи пищеводного отверстия диафрагмы у пациентов с гастроэзофагиальной рефлюксной болезнью / Н. А. Уварова, Н. В. Колпакова, М. Н. Сатывалдаев // Современные проблемы науки и образования. – 2017. – № 2, С. 45-53.

Вострякова Т. В. Частота выявления грыжи пищеводного отверстия диафрагмы у пациентов с гастроэзофагеальной рефлюксной болезнью / Т. В. Вострякова, Е.Н. Шлейкова, С. А. Пышкин // Эксперементальная и клиническая гастроентерология - 2014. - № 11. - С. 94.

Dominik Linz. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction / Dominik Linz, Hohl Mathias, Vollmar Johanna, et al. // EP Europace. – 2017. – 1.- Р. 16-20.

Ranjini R. Roy. Hiatal Hernia Is Associated With an Increased Prevalence of Atrial Fibrillation in Young Patients / Ranjini R. Roy, Sandeep Sagar, T. Jared Bunch et al. //J Atr Fibrillation. – 2013. -6(2). - Р. 894.

Huang C. C. Gastroesophageal reflux disease and atrial fibrillation: a nationwidepopulation-based study / C. C. Huang. W. L. Chan, J. C. Luo, Y. C. Chen, T. J. Chen, C. M. Chung, et al. // PLoS One. – 2012. - 7(10). - 47575.

Kunz J. S. Is there a link between gastroesophageal reflux disease and atrial fibrillation? / J. S. Kunz, B. Hemann, Atwood J. Edwin, J. Jackson, T. Wu, C. Hamm // Clin Cardiol. – 2009.- Oct. – 32 (10). – Р. 584-7.

Roman C. Atrial fibrillation in patients with gastroesophageal reflux disease: a comprehensive review / C. Roman, S. Bruley des Varannes, L. Muresan, A. Picos, D. L. Dumitrascu. // World J Gastroenterol. – 2014. - Jul 28. - 20(28). - Р. 9592-9.

Velagapudi P. Atrial fibrillation and acidreflux disease / P. Velagapudi, M. K. Turagam, M. A. Leal, A. G. Kocheril // Clin Cardiol. – 2012. – Mar. - 35(3). – Р. 180-6.

Bunch T. J. Long-term risk of atrial fibrillation with symptomaticgastroesophageal reflux disease and esophagitis / T.J. Bunch, D. L. Packer, A. Jahangir, G. R. Locke, N. J. Talley, B. J. Gersh, et al // Am J Cardiol. – 2008. – Nov. 1. - 102(9). – Р. 1207-11.

Floria M. Atrial fibrillation and gastroesophageal reflux disease:From the cardiologist perspective / M. Floria, V.L. Drug. // World J. Gastroenterol. – 2015. – Mar. 14. - 21(10). – Р. 3154-6.

Downloads

Published

2019-02-01

Issue

Vol. 8 No. 1 (2019)

Section

Medicine

License

Copyright (c) 2019 Health of Society

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.